Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma

MLA

Xiaoyan Xing, et al. “Identification and Validation of a Prognostic Signature and Combination Drug Therapy for Immunotherapy of Head and Neck Squamous Cell Carcinoma.” Computational and Structural Biotechnology Journal, vol. 19, Jan. 2021, pp. 1263–76. EBSCOhost, https://doi.org/10.1016/j.csbj.2021.01.046.

APA

Xiaoyan Xing, Weijie Qiang, Yifei Dai, & Xiaobo Sun. (2021). Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma. Computational and Structural Biotechnology Journal, 19, 1263–1276. https://doi.org/10.1016/j.csbj.2021.01.046

Chicago

Xiaoyan Xing, Weijie Qiang, Yifei Dai, and Xiaobo Sun. 2021. “Identification and Validation of a Prognostic Signature and Combination Drug Therapy for Immunotherapy of Head and Neck Squamous Cell Carcinoma.” Computational and Structural Biotechnology Journal 19 (January): 1263–76. doi:10.1016/j.csbj.2021.01.046.